{"entity":{"type":"insider","cik":"0001329959","url":"/insider/0001329959","json_url":"/insider/0001329959.json","name":"Gallagher Carol Giltner","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":18,"first":"2014-10-23","last":"2023-11-15","span_basis":"filed_date"},"name_variants":[{"name":"Gallagher Carol Giltner","source":"filing","n_filings":18,"first_seen":"2014-10-23","last_seen":"2023-11-15"}],"transactions":[{"id":8721220,"accession":"0000905148-23-001457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-23-001457","line_url":"/filing/0000905148-23-001457#line-2","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90980.0,"shares_display":"90,980","price_per_share":0.3098,"price_display":"0.31","price_state":"stated","total_value":28185.604,"total_display":"28,185.60","total_whole":"28,186","shares_owned_after":459418.0,"shares_owned_after_display":"459,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8721217,"accession":"0000905148-23-001457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001457","line_url":"/filing/0000905148-23-001457#line-1","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":179020.0,"shares_display":"179,020","price_per_share":0.2236,"price_display":"0.22","price_state":"stated","total_value":40028.872,"total_display":"40,028.87","total_whole":"40,029","shares_owned_after":368438.0,"shares_owned_after_display":"368,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-15","scope":"insider"},{"id":6142855,"accession":"0001209191-18-057696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-057696","line_url":"/filing/0001209191-18-057696#line-1","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21374.0,"shares_display":"21,374","price_per_share":36.38,"price_display":"36.38","price_state":"stated","total_value":777586.12,"total_display":"777,586.12","total_whole":"777,586","shares_owned_after":88818.0,"shares_owned_after_display":"88,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-07","scope":"insider"},{"id":6291962,"accession":"0001209191-18-038568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-038568","line_url":"/filing/0001209191-18-038568","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":44.7776,"price_display":"44.78","price_state":"stated","total_value":111944.0,"total_display":"111,944.00","total_whole":"111,944","shares_owned_after":110592.0,"shares_owned_after_display":"110,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-19","scope":"insider","n_lines":2},{"id":6454546,"accession":"0001209191-18-030723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-030723","line_url":"/filing/0001209191-18-030723#line-2","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":46.06,"price_display":"46.06","price_state":"stated","total_value":12574.38,"total_display":"12,574.38","total_whole":"12,574","shares_owned_after":111192.0,"shares_owned_after_display":"111,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-16","scope":"insider"},{"id":5959860,"accession":"0001209191-18-011674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-011674","line_url":"/filing/0001209191-18-011674#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":46.5,"price_display":"46.50","price_state":"stated","total_value":55009.5,"total_display":"55,009.50","total_whole":"55,010","shares_owned_after":110920.0,"shares_owned_after_display":"110,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-20","scope":"insider"},{"id":4226845,"accession":"0001209191-17-061600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-061600","line_url":"/filing/0001209191-17-061600#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":16812.8,"total_display":"16,812.80","total_whole":"16,813","shares_owned_after":109738.0,"shares_owned_after_display":"109,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-17","scope":"insider"},{"id":4359261,"accession":"0001209191-17-049452","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-049452","line_url":"/filing/0001209191-17-049452#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":16931.2,"total_display":"16,931.20","total_whole":"16,931","shares_owned_after":108556.0,"shares_owned_after_display":"108,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-17","scope":"insider"},{"id":4870276,"accession":"0001209191-17-039239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-039239","line_url":"/filing/0001209191-17-039239#line-2","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.15,"price_display":"13.15","price_state":"stated","total_value":13150.0,"total_display":"13,150.00","total_whole":"13,150","shares_owned_after":107374.0,"shares_owned_after_display":"107,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-09","filed_date":"2017-06-12","scope":"insider"},{"id":4266205,"accession":"0001209191-17-033206","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-033206","line_url":"/filing/0001209191-17-033206#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":15.25,"price_display":"15.25","price_state":"stated","total_value":18056.0,"total_display":"18,056.00","total_whole":"18,056","shares_owned_after":103374.0,"shares_owned_after_display":"103,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":5251208,"accession":"0001209191-17-011769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-011769","line_url":"/filing/0001209191-17-011769#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":16.1,"price_display":"16.10","price_state":"stated","total_value":19046.3,"total_display":"19,046.30","total_whole":"19,046","shares_owned_after":102192.0,"shares_owned_after_display":"102,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-16","scope":"insider"},{"id":2968589,"accession":"0001209191-16-150910","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-150910","line_url":"/filing/0001209191-16-150910#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":19.35,"price_display":"19.35","price_state":"stated","total_value":22910.4,"total_display":"22,910.40","total_whole":"22,910","shares_owned_after":99010.0,"shares_owned_after_display":"99,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-17","scope":"insider"},{"id":2317924,"accession":"0001209191-16-121441","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-121441","line_url":"/filing/0001209191-16-121441#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":15.96,"price_display":"15.96","price_state":"stated","total_value":18896.64,"total_display":"18,896.64","total_whole":"18,897","shares_owned_after":95462.0,"shares_owned_after_display":"95,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-18","scope":"insider"},{"id":2101408,"accession":"0001209191-16-100250","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-100250","line_url":"/filing/0001209191-16-100250#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":16.3,"price_display":"16.30","price_state":"stated","total_value":19282.9,"total_display":"19,282.90","total_whole":"19,283","shares_owned_after":94280.0,"shares_owned_after_display":"94,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-18","scope":"insider"},{"id":8377245,"accession":"0001209191-15-081091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-081091","line_url":"/filing/0001209191-15-081091#line-3","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":31.1,"price_display":"31.10","price_state":"stated","total_value":36822.4,"total_display":"36,822.40","total_whole":"36,822","shares_owned_after":93098.0,"shares_owned_after_display":"93,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-18","scope":"insider"},{"id":8226227,"accession":"0001209191-15-067634","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-067634","line_url":"/filing/0001209191-15-067634","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5874.0,"shares_display":"5,874","price_per_share":40.50666666666667,"price_display":"40.51","price_state":"stated","total_value":237936.16,"total_display":"237,936.16","total_whole":"237,936","shares_owned_after":93195.0,"shares_owned_after_display":"93,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-24","filed_date":"2015-08-24","scope":"insider","n_lines":4},{"id":8226213,"accession":"0001209191-15-067634","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-067634","line_url":"/filing/0001209191-15-067634","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5874.0,"shares_display":"5,874","price_per_share":41.711777323799794,"price_display":"41.71","price_state":"stated","total_value":245014.98,"total_display":"245,014.98","total_whole":"245,015","shares_owned_after":98238.0,"shares_owned_after_display":"98,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-24","scope":"insider","n_lines":2},{"id":8226207,"accession":"0001209191-15-067634","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-067634","line_url":"/filing/0001209191-15-067634","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5874.0,"shares_display":"5,874","price_per_share":44.79726251276813,"price_display":"44.80","price_state":"stated","total_value":263139.12,"total_display":"263,139.12","total_whole":"263,139","shares_owned_after":103664.0,"shares_owned_after_display":"103,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-24","scope":"insider","n_lines":3},{"id":8188348,"accession":"0001209191-15-067018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-067018","line_url":"/filing/0001209191-15-067018","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":48.18425531914894,"price_display":"48.18","price_state":"stated","total_value":283082.5,"total_display":"283,082.50","total_whole":"283,083","shares_owned_after":111038.0,"shares_owned_after_display":"111,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-19","scope":"insider","n_lines":2},{"id":8188341,"accession":"0001209191-15-067018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-067018","line_url":"/filing/0001209191-15-067018#line-4","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5764.0,"shares_display":"5,764","price_per_share":49.38,"price_display":"49.38","price_state":"stated","total_value":284626.32,"total_display":"284,626.32","total_whole":"284,626","shares_owned_after":115413.0,"shares_owned_after_display":"115,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8337794,"accession":"0001209191-15-015499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-015499","line_url":"/filing/0001209191-15-015499#line-1","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":198000.0,"total_display":"198,000.00","total_whole":"198,000","shares_owned_after":62656.0,"shares_owned_after_display":"62,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-18","scope":"insider"},{"id":7035344,"accession":"0001209191-14-064592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-064592","line_url":"/filing/0001209191-14-064592#line-2","is_derivative":false,"issuer_cik":"0001329959","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001329959","owner_cik":"0001329959","owner_name":"Gallagher Carol Giltner","owner_display_name":"Gallagher Carol Giltner","owner_url":"/insider/0001329959","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18181.0,"shares_display":"18,181","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":199991.0,"total_display":"199,991.00","total_whole":"199,991","shares_owned_after":51656.0,"shares_owned_after_display":"51,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-21","filed_date":"2014-10-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Director","n_filings":18,"first_seen":"2014-10-23","last_seen":"2023-11-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001329959","retrieved_at":"2026-08-22T16:13:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}